Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 28 for “"CPT-11"”.
-
Expression and characterization of CPT-11 carboxylesterases in human liver and cancer cell lines
This document only includes an excerpt of the corresponding thesis or dissertation. To request a digital scan of the full text, please contact the Ruth Lilly Medical Library's Interlibrary Loan Department (rlmlill@iu.edu).
-
Ο ρόλος της Ιρινοτεκάνης (CPT-11) στη θεραπευτική αντιμετώπιση του μεταστατικού καρκίνου του παχέος εντέρου
… was found to be 600 mg/m2/day days 1-4 and for CPT-11 350 mg/m2 in day 4. Dose limiting toxicities were neutropenic fever, neutropenia, diarrhea and mucositis, with an overall response rate (ORR) 22%. The phase II trial of the FOLFIRI combination showed that it is an active and safe regimen is …
-
Pharmacokinetic and pharmacodynamic mechanisms for reduced toxicity of CPT-11 by thalidomide and St John's wort
… and myelosuppression hinder the clinical use of CPT-11-based dose-intensified regimens. Clinical studies indicated that combination with thalidomide or St. Johna??s wort (SJW) alleviated CPT-11 induced toxicity. However, the underlying mechanisms involved are not fully understood. In this thesis, …
-
Σχέση των πολυμορφισμών του γονιδίου UGT1A με την τοξικότητα της ιρινοτεκάνης (CPT-11) σε Έλληνες ασθενείς σε συμπαγείς όγκους
Uridine Glucuronosyltransferase (UGT) gene polymorphisms have been linked to irinotecan toxicity.UGT1A1 is the responsible enzyme for the detoxification of the active metabolite of the drug (SN-38) in the liver. UGT1A7 is believed to participate in the detoxification of SN-38 in the gut. UGT …
-
Development of liposomal Irinotecan (CPT-11) formulation and understanding of its therapeutic potential in combination with immunotherapies in colorectal cancer models
Irinotecan (CPT-11) is a key chemotherapeutic drug for various solid tumors, including colorectal cancer (CRC). However, its clinical use is limited by unfavorable pharmacokinetics, rapid interconversion to inactive form, and dose-limiting gastrointestinal (GI) toxicity. Liposomal drug delivery …
-
Effect of p53 or hMLH1 status on the mechanisms of cytotoxicity of 7-hydroxystaurosporine (UCN-01) or irinotecan (CPT-11) in colorectal cancer cell lines
… 7-hydroxystaurosporine (UCN-01) or irinotecan (CPT-11) was investigated. For this purpose a colorectal carcinoma cell line HCT116 (which has the genotype p53+/+,hMLH1-) and the two derivative cell lines HCT116+ch3 (p53+/+,hMLH1+) and HCT116 p53-/- (p53-/-,hMLH1-) were used. …
-
The Combination of Carboxylesterase-Expressing Oncolytic Vaccinia Virus and Irinotecan
… oncolytic Vaccinia virus (VV) with irinotecan (CPT-11) for the treatment of cancer. VV can infect, replicate in and destroy cancer cells, yet leave healthy cells relatively unaffected. CPT-11 is a chemotherapeutic of which ~5% is converted to the more active chemotherapeutic SN-38 by endogenous …
-
A importância da seqüência de administração do irinotecan e 5-fluorouracil na inibição da proliferação do carcinoma de cólon humano in vitro
… o inibidor da topoisomerase I irinotecan (CPT-11) demonstrou, em carcinoma de cólon avançado, respostas comparáveis tanto em pacientes não tratados quanto naqueles que tiveram recaída após terapia com 5-FU. Estes resultados justificam a avaliação da combinação 5-FU/CPT-11 nesta doença. …
-
Untersuchung des Einflusses genetischer Läsionen in Kolonkarzinomzellen auf ihre Empfindlichkeit gegenüber chemotherapeutischen Agenzien
… Zusammenhang jedoch sowohl für 5-FU als auch für CPT-11 ausgeschlossen werden. Somit zeigt dieser Teil der Untersuchung die Notwendigkeit, verschiedene Methoden zur Bestimmung der Chemoresistenz von Tumorzellen anzuwenden. Der klonogene Test scheint für Voraussagen über langfristige Effekte am …
-
Oncolytic Vaccinia Virus for the Treatment of Peritoneal Carcinomatosis: Combination with Chemotherapy and Targeted Radiotherapy
… chemotherapy drugs, oxaliplatin and irinotecan (CPT-11), we observed synergistic improvements in in vitro tumour cell death and improved in vivo survival in tumour-bearing mice (with CPT-11). Synergy was attributed to sensitization of cells to drug treatment due to VV-induced S-phase arrest. In …
-
Κυτταρογενετικός έλεγχος της δράσης της ερυθροποιητίνης σε λεμφοκύτταρα περιφερικού αίματος ανθρώπου in vitro και σε καρκινικά κύτταρα P388 σε πειραματόζωα in vivo
… C (MMC) and a camptothecin analogue, irinotecan (CPT-11). After cultivating cells in the presence of the studied factors, according to the related experimental protocol, and evaluating the results the following research results were reached: I. When Epo added alone to lymphocyte cultures and P388 …
-
Rational design and synthesis of drug delivery platforms for treating diseases associated with intestinal inflammation
… that target the chemotherapeutic irinotecan (CPT-11) to solid tumors, and thus abrogates CPT-11-mediated drug resistance and inhibits tumor growth. In order to maximize the amount of NF-κB inhibitor delivered to tumors, we synthesized a novel polymeric prodrug, termed PCAPE, that releases the …
-
Assessing Chemotherapy-Induced Bone Loss and a Novel Dietary Approach to Mitigate Bone Loss
… burden following treatment. Camptothecin-11 (CPT-11), an antineoplastic enzyme inhibitor chemotherapy, used in the treatment of some solid cancers cancer has been investigated for its effects on the gastrointestinal system. However, the effects of CPT-11 on bone health remain unclear. …
-
Exploring the Effects of Toll-Like Receptor 4 Antagonism on Gastrointestinal Mucositis and Tumour Activity
… on GI toxicity stemming from irinotecan/CPT-11, a DNA topoisomerase I inhibitor used in the treatment of advanced colorectal cancer. The TLR4 antagonists studied were TAK-242 and IAXO-102, due to their potential to serve as alternative treatment options for GIM. Firstly, I modelled …
-
Design, Synthesis, and Evaluation of Novel Positron Emission Tomography Radiotracers
… measure the enzymatic activation of Irinotecan (CPT-11), a potent chemotherapeutic used in the treatment of colon cancer and several pediatric solid tumors. CPT-11 itself is a prodrug which is converted in vivo to SN-38, via metabolism by carboxylesterase (CE) enzymes. St. Jude Children’s …
-
Κυτταρογενετική και μοριακή μελέτη σε γυναίκες με το σύνδρομο των πολυκυστικών ωοθηκών
… by the antineoplastic agents camptothecin-11 (CPT-11) (for SCEs) and mitomycin C (MMC) in MN. These agents used as a positive control. Finally, the content of MN and a possible X chromosome malsegregation were assessed in women with PCOS. Results: Females with PCOS showed increased …
-
Estudio de vías de señalización desencadenadas por el análogo tumoral de la hormona paratiroidea (PTHrP) involucradas en eventos que favorecen el comportamiento agresivo de las células tumorales intestinales
… receptor tirosina quinasa Met en las células HCT116, derivadas de CCR, pero no en la línea celular más diferenciada Caco-2. Este efecto es mediado por la activación de la quinasa citosólica Src y por la vía de señalización de las MAPK con participación de ERK1/2 y p38 MAPK. Previo al inicio de …
-
Catabolic Effects of Chemotherapy Drugs-Inflammatory Cytokines Combination on Myotubes and Endothelial Cells
… endothelial cells. Myotubes were treated with CPT-11 (20 μg/mL), 5-fluorouracil (50 μg/mL), leucovorin (10 μg/mL), IL-6 (20 ng/mL), and TNF-α (100 ng/mL). Treatment significantly reduced myofibrillar proteins, including MHC-1(−36%), tropomyosin (−65%), and troponin T (−76%), and suppressed …
Page 1 of 2